Skip to main content

MoneyWorks4Me

Everest Organics informs about listing approval

12 Mar 2025 Evaluate
Everest Organics has informed that the Company has received listing approval from BSE vide their letter bearing no: LOD/PREF/VK/FIP/1940/2024-25 dated March 11, 2025 for listing of 17,10,526 Equity shares of Rs 10 each issued to non-promoters on preferential basis. The approval letter received from BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1776.00
Dr. Reddys Labs. 1372.00
Cipla 1400.10
Lupin 2015.00
Zydus Lifesciences 1190.00
View more..